Calendar · pharmadog

Week of Apr 13, 2026

Apr 16, 2026grant86d agoEMORY UNIVERSITY — Understanding Multidrug-Resistant Pathogen Infections and their Treatment wit...Emory University

AI grant. $161,244. PI: TERESA GIL GIL

full page →nih reporter ↗

Apr 16, 2026grant86d agoUNIVERSITY OF PENNSYLVANIA — Metabolic Imaging Using Hyperpolarized Agents at Tracer ConcentrationsUniversity of Pennsylvania

CA grant. $415,623. PI: STEPHEN J KADLECEK

full page →nih reporter ↗

Apr 16, 2026grant86d agoBOSTON CHILDREN'S HOSPITAL — Molecular Mechanisms of Aire in Transcriptional RegulationBoston Children's Hospital

AI grant. $267,000. PI: Qianxia Zhang

full page →nih reporter ↗

Apr 16, 2026grant86d agoUNIVERSITY OF PITTSBURGH AT PITTSBURGH — The molecular and physiologic effects of calcineurin inhibitors on WNK body b...

DK grant. $769,882. PI: Cary Ragan Boyd-Shiwarski

full page →nih reporter ↗

Apr 16, 2026grant86d agoUNIV OF MASSACHUSETTS MED SCH WORCESTER — Examining the Effectiveness of School-based Health Centers (SBHCs) to Improve...

NR grant. $3,480,544. PI: Michelle Trivedi

full page →nih reporter ↗

Apr 16, 2026grant86d agoUNIVERSITY OF MICHIGAN AT ANN ARBOR — Volatile Organic Compound Impacts on Immune Functions During Pregnancy: Molec...

ES grant. $795,869. PI: Sean M Harris

full page →nih reporter ↗

Apr 16, 2026grant86d agoLOUISIANA STATE UNIV HSC SHREVEPORT — The role of ZBP1 in controlling HSV-1 pathogenesis

AI grant. $660,723. PI: Hongyan Guo

full page →nih reporter ↗

Apr 16, 2026grant86d agoICAHN SCHOOL OF MEDICINE AT MOUNT SINAI — Determinants of viral assembly and infectivity within the Ebola virus VP24 pr...

AI grant. $843,182. PI: Christopher F Basler

full page →nih reporter ↗

Apr 16, 2026grant86d agoUNIVERSITY OF CALIFORNIA, SAN DIEGO — The effects and mechanisms supporting psilocybin induced pain reliefUniversity of California San Diego

AT grant. $788,967. PI: ADAM L. Halberstadt

full page →nih reporter ↗

Apr 17, 2026approval85d agoSODIUM ACETATE — FDA approvalSODIUM ACETATE

Sponsor: EXTROVIS. Form: SOLUTION. Route: INTRAVENOUS

full page →SODIUM ACETATE →fda approvals ↗

Apr 17, 2026approval85d agoCOSENTYX (SECUKINUMAB) — FDA approvalNOVARTIS AG

Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Apr 17, 2026approval85d agoCOSENTYX (SECUKINUMAB) — FDA approvalNOVARTIS AG

Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Apr 17, 2026approval85d agoCOSENTYX (SECUKINUMAB) — FDA approvalNOVARTIS AG

Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Apr 17, 2026approval85d agoCOSENTYX (SECUKINUMAB) — FDA approvalNOVARTIS AG

Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Apr 17, 2026approval85d agoVALPROIC ACID — FDA approvalVALPROIC ACID

Sponsor: QUAGEN. Form: SYRUP. Route: ORAL

full page →VALPROIC ACID →fda approvals ↗

Apr 17, 2026approval85d agoCARBAMAZEPINE — FDA approvalcarbamazepine ER

Sponsor: YICHANG HUMANWELL. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →carbamazepine ER →fda approvals ↗

Apr 17, 2026approval85d agoCALCIPOTRIENE — FDA approvalPrasco LLC

Sponsor: GLENMARK SPECLT. Form: CREAM. Route: TOPICAL

full page →fda approvals ↗

Apr 17, 2026approval85d agoESOMEPRAZOLE MAGNESIUM — FDA approvalesomeprazole magnesium DR

Sponsor: MARKSANS PHARMA. Form: CAPSULE, DELAYED RELEASE. Route: ORAL

full page →esomeprazole magnesium DR →fda approvals ↗

Apr 17, 2026approval85d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

Sponsor: GLENMARK PHARMS LTD. Form: TABLET, FOR SUSPENSION. Route: ORAL

full page →LAMOTRIGINE →fda approvals ↗

Apr 17, 2026approval85d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

Sponsor: GLENMARK PHARMS LTD. Form: TABLET, FOR SUSPENSION. Route: ORAL

full page →LAMOTRIGINE →fda approvals ↗

Apr 17, 2026approval85d agoTETRACYCLINE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals of New York LLC

Sponsor: IMPAX LABS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Apr 17, 2026approval85d agoTETRACYCLINE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals of New York LLC

Sponsor: IMPAX LABS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Apr 17, 2026grant85d agoUNIVERSITY OF WASHINGTON — Mentoring patient-oriented research on point-of-care diagnostics for infectio...University of Washington

AI grant. $209,758. PI: Paul K Drain

full page →nih reporter ↗

Apr 17, 2026grant85d agoUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — Assessing multi-site feasibility of an integrated whole-body hyperthermia and...University of California San Francisco

AT grant. $601,259. PI: Ashley E. Mason

full page →nih reporter ↗

Apr 17, 2026grant85d agoUNIVERSITY OF SOUTH FLORIDA — Aligning Circuit-Directed Rehabilitation with HPA Axis for Improved TBI Recovery

NS grant. $568,920. PI: Theresa Currier Thomas

full page →nih reporter ↗

Apr 17, 2026grant85d agoNORTHWESTERN UNIVERSITY AT CHICAGO — Disrupting the Peri-necrotic Engine of Immunosuppression in GlioblastomaNorthwestern University

CA grant. $496,357. PI: DANIEL J BRAT

full page →nih reporter ↗

Apr 17, 2026grant85d agoMASSACHUSETTS GENERAL HOSPITAL — Toolkit for Optimal Pain Management in the Emergency Department: A mind-body ...Massachusetts General Hospital

AT grant. $170,640. PI: Julia E. Hooker

full page →nih reporter ↗

Apr 17, 2026grant85d agoRUTGERS BIOMEDICAL AND HEALTH SCIENCES — Novel Pediatric TB Diagnostics using Host and Microbial Biomarkers

AI grant. $210,302. PI: William Evan Johnson

full page →nih reporter ↗

Apr 17, 2026grant85d agoUNIVERSITY OF MICHIGAN AT ANN ARBOR — Remote Loading of Melanocortin and GLP-1 Peptides in Polymers for Treatment o...

DK grant. $231,000. PI: Roger D. Cone

full page →nih reporter ↗

Apr 17, 2026grant85d agoRESEARCH TRIANGLE INSTITUTE — Development of Neuromedin Receptor 2 antagonists as Novel Analgesics

NS grant. $230,562. PI: Thuy Nguyen

full page →nih reporter ↗

Apr 17, 2026grant85d agoUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — Analyzing the Distribution, Effectiveness, and Implementation of Wildfire Smo...University of California San Francisco

ES grant. $117,747. PI: Rebecca Sugrue

full page →nih reporter ↗

Week of Apr 20, 2026

Apr 20, 2026approval82d agoCANAGLIFLOZIN — FDA approvalCANAGLIFLOZIN

Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL

full page →CANAGLIFLOZIN →fda approvals ↗

Apr 20, 2026approval

Week of Apr 27, 2026

Apr 30, 2026filing72d agoXbrane Biopharma AB — ranibizumab biosimilar (NDA/BLA Filing (US))ranibizumab biosimilar

Therapy area: Ophthalmology. Indication: Wet (Neovascular / Exudative) Macular Degeneration

full page →ranibizumab biosimilar →source: globaldata

Apr 30, 2026filing

Week of Jul 6, 2026

07/08/2026adcom3d agoAdvisory Committee Calendar

This page contains notices of advisory committee meetings. Refer to the individual meeting link below for more information on the anticipated format of each meeting. For previous years' advisory committee calendars, see the FDA Archive.

full page →fda adcom ↗

Date TBD

TBDapprovalOZURDEX (DEXAMETHASONE) — FDA approvaldexamethasone LA

Sponsor: ABBVIE. Form: IMPLANT. Route: INTRAVITREAL

full page →dexamethasone LA →fda approvals ↗

TBDapproval

← prev

page 4 of 4